Entrada Therapeutics, Inc.
TRDANasdaqCIK 1689375HealthcareFiscal year ends Dec 31
Reports and events: 88 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-09-2916:39 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-105351 |
| 2023-09-2107:09 ET | 8-K | 8.01 Other events | 0001689375-23-000068 |
| 2023-08-1007:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-089549 |
| 2023-08-0807:25 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-03-31 | 0001104659-23-088600 |
| 2023-08-0807:23 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001104659-23-088597 |
| 2023-08-0807:14 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001689375-23-000055 |
| 2023-08-0807:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-23-000053 |
| 2023-08-0107:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-086035 |
| 2023-06-0817:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-23-069464 |
| 2023-05-1007:45 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001689375-23-000039 |
| 2023-05-1007:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-23-000036 |
| 2023-04-2507:00 ET | DEF 14A | Proxy statementPeriod 2023-06-08 | 0001104659-23-049258 |
| 2023-04-0407:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001689375-23-000023 |
| 2023-03-0607:21 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001689375-23-000019 |
| 2023-03-0607:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-23-000017 |
| 2023-02-0907:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689375-23-000008 |
| 2023-01-0907:06 ET | 8-K | 8.01 Other events | 0001689375-23-000003 |
| 2022-12-1916:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-128270 |
| 2022-12-0807:09 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-125317 |
| 2022-11-0707:39 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001689375-22-000045 |
| 2022-11-0707:24 ET | 8-K | 2.02 Results of operations | 0001689375-22-000043 |
| 2022-08-1107:20 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001689375-22-000013 |
| 2022-08-1107:07 ET | 8-K | 9.01 Financial statements and exhibits | 0001689375-22-000010 |
| 2022-06-0316:19 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-068101 |
| 2022-05-1207:24 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001689375-22-000004 |
| 2022-05-1207:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-059069 |
| 2022-04-1916:13 ET | DEF 14A | Proxy statementPeriod 2022-06-02 | 0001104659-22-047338 |
| 2022-03-2207:41 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-22-036320 |
| 2022-03-1507:49 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-003614 |
| 2022-03-1507:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-033618 |
| 2021-12-1617:23 ET | SC 13D | Ownership report, active investor | 0001104659-21-150588 |
| 2021-12-0916:03 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-016637 |
| 2021-12-0907:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-147869 |
| 2021-11-1216:30 ET | SC 13D | Ownership report, active investor | 0001104659-21-138124 |
| 2021-11-1216:07 ET | SC 13D | Ownership report, active investor | 0001193125-21-328063 |
| 2021-11-0216:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-21-132980 |
| 2021-10-2506:05 ET | S-1/A | Registration statement, amended | 0001104659-21-129181 |
| 2021-10-0817:00 ET | S-1 | Registration statement | 0001104659-21-124689 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 11:57 ET. Listed shows no prices and gives no investment advice.